Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Webinar to address OA breakthrough pain
Matt Gurney, specialist in Anasethesia and Analglasia, will lead the webinar.
The webinar is the first in a series of accelerator events by the London Vet Show. 

Animalcare Ltd is holding a free online CPD event which will address osteoarthritis (OA) breakthrough pain in pets.

Led by Matt Gurney, RCVS and EBVS European veterinary specialist in Anaesthesia and Analgesia, the webinar marks the first of many communication events which aim to focus on breakthrough pain in pets with canine osteoarthritis.

The London Vet Show is running several of these accelerator events, beginning with this session, which will address areas of increasing importance in veterinary medicine. These sessions will culminate in a roundtable later in the year, where experts in the field will address the most relevant information on the topic.

The topic of osteoarthritis breakthrough pain has been chosen for this session because the topic is currently of great interest to the profession, with 80 per cent of owners who have pets with canine osteoarthritis believing that their pet may be suffering with breakthrough pain, whilst 87 per cent of vets agree that avoiding osteoarthritis breakthrough pain is critical to the management of canine OA. 

James Beaumont, marketing manager at Animalcare, said: “Veterinary surgeons have told us that they estimate that nearly half of their canine OA cases on daily NSAIDs experience breakthrough pain. 

“Additionally, a proportion of pet owners state their dogs experience off-days and believe their pet suffers as a result of the condition. We’re very pleased to be bringing this important issue to the forefront of attention and making it a talking point for the profession.”

In the session, Matt Gurney will explain the impact of breakthrough pain on both the pet and the owner, and discuss how to approach it more effectively using analgesic and rehabilitation tools and strategies. This expertise coming from his Zero Pain Philosophy programme, in which he works with veterinary professionals across the world to improve their approach to pain management.

The event takes place on 13 July at 7pm BST, and is open to veterinary surgeons who wish to support their canine osteoarthritis cases more effectively.

All those who register will also be able to view a recording, and enter a free prize draw for the chance to win tickets to the London Vet Show in November. 

Registration is open at bigmarker.com/closerstill-media

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.